Product Series


Commercial API Portfolio

Therapeutic Category

Product Name

DMF/GMP

Antibacterial Sulfanilamide

Sulfasalazine  

CEP, Brazil, Korea

Sulfadimethoxine 

USDMF, ASMF

Sulfadimethoxine Sodium

USDMF, ASMF

Antibiotic

Meropenem  

JDMF

Anticonvulsant

Carbamazepine

USDMF, CEP, CADIFA,

 Korea, ANVISA GMP

Oxcarbazepine 

ASMF, NMPA DMF, USDMF

Lacosamide

NMPA DMF

PD

Rasagiline Mesylate

NMPA DMF

Antidiabetic

Gliclazide   

CEP, JDMF, Canada,

India, CADIFA

Sitagliptin Hydrochloride

ASMF

Sitagliptin Phosphate

ASMF, USDMF,

NMPA DMF

Antihyperlipidemic

Bezafibrate 

ASMF

Non-Steroid Anti-Inflammatory

Dexketoprofen Trometamol

ASMF, EUGMP

Ketoprofen   

CEP, JDMF, CADIFA,

NMPA DMF, EUGMP

Ketoprofen Lysinate

ASMF, EUGMP

Anti-Cancer

Imatinib Mesylate  

 CEP, USDMF,

ASMF, NMPA DMF

Axitinib  

USDMF

Gefitinib 

CEP, USDMF, NMPA DMF

Erlotinib Hydrochloride

NMPA DMF

Antiviral

Tenofovir Disoproxil

Succinate

ASMF

Acyclovir

USDMF, CEP

Antidepressant

Venlafaxine Hydrochloride 

USDMF, CEP, NMPA DMF

ED

Sildenafil Citrate

USDMF, CEP, NMPA DMF

Antithrombin

Cilostazol

NMPA DMF

Anti-Hypertension

Atenolol

USDMF, CEP, JDMF

Anti-SARS-CoV-2

*Nirmatrelvir

MPP License, WHO GMP

Products under protection of valid patent are not offered to the countries where the patent law is in force. It's the buyer's responsibility and liability to check the patent situation in target market(s).

Products should be developed for commercial use only in areas where the products have been registered and would not infringe any third party’s patents, otherwise products could only be used for research purpose.